Article
Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphism.
British journal of clinical pharmacology - 1 Sept 1991
Turgeon J, Evans W E, Relling M V, Wilkinson G R, Roden D M
Abstract excerpt
1. The major pathway for 4-hydroxylation of debrisoquine in man is polymorphic and under genetic control. More than 90% of subjects (extensive metabolizers, EMs) have active debrisoquine 4-hydroxylase (cytochrome P450IID6) while in the remainder (poor metabolizers, PMs), cytochrome P450IID6 activity is greatly impaired. 2. Within the EM group, cytochrome P450IID6-mediated metabolism of a range of substrates...
Topics
- Autoradiography
- Blotting, Southern
- Cytochrome P-450 CYP2D6
- Cytochrome P-450 Enzyme System
- DNA
- Encainide
- Genotype
- Humans
- Mixed Function Oxygenases
- Phenotype
- Polymorphism, Restriction Fragment Length
